Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In this narrative review, we discuss pharmacological therapeutic options for MASH with a focus on newly approved or promising metabolism-based pharmacotherapies currently being evaluated in late-phase RCTs for the treatment of this common and burdensome liver disease
Those on blood thinners should know that BPC-157 interacts with the coagulation system, though specific clinical significance remains unclear
Clinical impacts of sun exposures on the faces and hands of Japanese women of different ages
The use of prazosin, an 1-adrenergic receptor blocker, showed that the ability of GLP-1RAs to reduce TNF- in plasma was disrupted, signifying the vital role of 1-adrenergic receptors in the anti-inflammatory action of GLP-1RAs
US$ 23.18
US$ 29.97
US$ 22.47
US$ 23.92
US$ 23.10
